In the latest trading session, 0.56 million Windtree Therapeutics Inc (NASDAQ:WINT) shares changed hands as the company’s beta touched 0.56. With the company’s most recent per share price at $1.47 changed hands at -$0.6 or -28.99% at last look, the market valuation stands at $2.37M. WINT’s current price is a discount, trading about -1736.73% off its 52-week high of $27.00. The share price had its 52-week low at $2.02, which suggests the last value was -37.41% down since then. When we look at Windtree Therapeutics Inc’s average trading volume, we note the 10-day average is 0.61 million shares, with the 3-month average coming to 1.40 million.
Analysts gave the Windtree Therapeutics Inc (WINT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WINT as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Windtree Therapeutics Inc’s EPS for the current quarter is expected to be -2.27.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Instantly WINT was in red as seen in intraday trades today. With action -49.31%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -88.64%, with the 5-day performance at -49.31% in the red. However, in the 30-day time frame, Windtree Therapeutics Inc (NASDAQ:WINT) is -53.92% down. Looking at the short shares, we see there were 35911.0 shares sold at short interest cover period of 0.03 days.
Windtree Therapeutics Inc (WINT) estimates and forecasts
Data shows that the Windtree Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -78.51% over the past 6 months, a 97.47% in annual growth rate that is considerably higher than the industry average of 17.80%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 66.05%. The 2024 estimates are for Windtree Therapeutics Inc earnings to increase by 97.48%.
WINT Dividends
Windtree Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Nov-07.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.47% of Windtree Therapeutics Inc shares while 3.25% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.30%.
